These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 19476572)

  • 1. Now or never: optimal antihypertensive therapy in the elderly.
    Prisant LM
    Prev Cardiol; 2008; 11(4):201-9. PubMed ID: 19476572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of four primary classes of antihypertensive monotherapy in Thai patients.
    Sukonthasarn A
    J Med Assoc Thai; 2000 Oct; 83(10):1202-10. PubMed ID: 11143486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special considerations for antihypertensive agents in dialysis patients.
    Redon J; Martinez F; Cheung AK
    Blood Purif; 2010; 29(2):93-8. PubMed ID: 20093810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed dose combination therapy in the treatment of hypertension.
    Stanton T; Reid JL
    J Hum Hypertens; 2002 Feb; 16(2):75-8. PubMed ID: 11850763
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
    Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
    BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of pharmacological blood pressure lowering mechanisms.
    Lonn E
    Can J Cardiol; 2004 Aug; 20 Suppl B():83B-88B. PubMed ID: 15309210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
    White WB
    Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial therapy of hypertension.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1140-2. PubMed ID: 15863559
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic treatment of the elderly hypertensive: comparative efficacy and side effects.
    Schnaper HW
    Geriatrics; 1989 Oct; 44 Suppl B():44-8. PubMed ID: 2572515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of hypertension--what treatment for what patients?].
    Zidek W; Tepel M; van der Giet M
    MMW Fortschr Med; 2004 May; 146(22):31-4. PubMed ID: 15373106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].
    González Maqueda I; Gómez Guindal JA; González Lama I
    Rev Esp Cardiol; 1999; 52 Suppl 3():59-72. PubMed ID: 10614151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interactions between antihypertensive drugs].
    Takagi M; Matsuoka H
    Nihon Rinsho; 1992 May; 50 Suppl():23-27. PubMed ID: 1355126
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive drugs: adverse reactions and metabolic effects in elderly patients.
    Gifford RW
    Geriatrics; 1989 Oct; 44 Suppl B():37-43. PubMed ID: 2572514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination therapy in hypertension].
    Tsukiyama H; Shigemasa T; Kobayashi I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():328-32. PubMed ID: 16981563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.